Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP1891019

2,6-SUBSTITUTED-4-MONOSUBSTITUTEDAMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    14.10.2005
  • EP published:
    25.7.2012
  • EP application number:
    05812481.9
  • Max expiry date:
    13.10.2025
  • Title:
    2,6-SUBSTITUTED-4-MONOSUBSTITUTEDAMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS

Timeline

Today
14.10.2005EP application
25.7.2012EP Publication

Owner

  • Name:
    Aventis Pharmaceuticals Inc.
  • Address:
    55 Corporate Drive, 08807, Bridgewater, NJ, US

Inventor

  • Name:
    LIM, Sungtaek
  • Address:
    Flemington, NJ, US
  • Name:
    HARRIS, Keith John
  • Address:
    Chester, NJ, US
  • Name:
    STEFANY, David
  • Address:
    Hillsborough, NJ, US
  • Name:
    GARDNER, Charles J.
  • Address:
    Royersford, PA, US
  • Name:
    CAO, Bin
  • Address:
    Bedminster, NJ, US
  • Name:
    BOFFEY, RayArgenta Discovery Ltd.
  • Address:
    Essex CM19 5TR, UK, GB
  • Name:
    GILLESPY, Timothy A.
  • Address:
    Hillsborough, NJ, US
  • Name:
    AGUIAR, Joacy, C.
  • Address:
    Newark, NJ, US
  • Name:
    HUNT, Hazel J.
  • Address:
    Harlow, Essex CM19 5TR, UK, GB
  • Name:
    DECHAUX, Elsa A.
  • Address:
    Harlow, Essex CM19 5TR, UK, GB

Priority

  • Number:
    619272 P
  • Date:
    15.10.2004
  • Country:
    US

Classification

  • Categories:
    C07D 239/46, C07D 409/04, C07D 413/04, C07D 403/04

Upload documents